News
Protara Therapeutics announced promising results from its Phase 2 ADVANCED-2 trial for TARA-002, an investigational therapy for high-risk non-muscle invasive bladder cancer (NMIBC). The study ...
MSI (Micro-Star International Co., Ltd, Chinese: 微星科技股份有限公司) is a Taiwanese multinational information technology corporation headquartered in New Taipei City, Taiwan. It designs, develops and provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback